Mentice Year-end Report Q4, Oct - Dec 2024
Read more
Mentice Secures $648,410 USD Combined Order for Advanced Simulation Solutions from a Top 20 Global MedTech company
Learn More
English / Svenska
Investor > Press Releases >
Correction: Mentice publishes Annual Report 2023

Correction: Mentice publishes Annual Report 2023

Wednesday, April 24, 2024

Updated URL

Mentice (publ), Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, today published its Annual Report and Sustainability Report 2023.

2023 - A good year and a solid foundation for continued growth

  • Net sales increased by more than 25 per cent.
  • Strong market development in North America.
  • Important certificates secured and strategic acquisition of Biomodex.


Read more about Mentice’s operations, markets, and strategy going forward.

The Annual Report 2023 is available to shareholders and other interested parties at investor.mentice.com/financial-reports-and-presentations/mentice-annual-report-2023. A printed copy can be obtained upon written request to stacy.hammar@mentice.com.

For more information, please contact:
Göran Malmberg, CEO, Mentice
E-post: goran.malmberg@mentice.com
US Mobile. +1 (312) 860 5610
Sweden Mobile +46 (0) 703 09 22 22

About Mentice
Mentice (STO: MNTC) is the world leader in proficiency based simulation solutions for image guided interventional therapies. Our solutions help healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. Mentice solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular, and peripheral interventions are just some of the clinical areas covered by our solutions. Learn more about the features and benefits of Mentice solutions at: www.mentice.com

Marketplace| Nasdaq First North Growth Market, Stockholm | Ticker symbol MNTC
Certified Adviser| FNCA Sweden AB

Image Attachments
AR 2023 IMG

Attachments
Annual Report 2023 Mentice

SHARE INFORMATION
The StockTop 10 ShareholdersCertified Advisor
PRESS RELEASES
All2022202120202019
FINANCIAL CALENDAR
Financial Calendar
financial reports
All
2022
2021
2020
2019
2023
2024
2025
CORPORATE GOVERNANCE
Corporate GovernanceArticle of AssociationGeneral MeetingsBoard of DirectorsSenior ManagementAuditorsBoard CommitteesCorporate Share HoldingsGuidelines for RemunerationNomination CommitteeSustainabilityMedia
other
About usContactCompany PresentationBack to Mentice
Data PolicyQuality PolicyDisclaimerTerms
Copyright © 2023 Mentice AB (publ) . All rights reserved.
Mentice Bokslutskommuniké, Jan - Dec 2024
Läs mer
Mentice får en total order på avancerade simuleringslösningar värd $648,410 USD från ett topp 20 globalt medtech bolag
Läs Mer
English / Svenska
Investor > Pressmeddelanden >
Correction: Mentice publishes Annual Report 2023

Correction: Mentice publishes Annual Report 2023

Wednesday, April 24, 2024

Updated URL

Mentice (publ), Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, today published its Annual Report and Sustainability Report 2023.

2023 - A good year and a solid foundation for continued growth

  • Net sales increased by more than 25 per cent.
  • Strong market development in North America.
  • Important certificates secured and strategic acquisition of Biomodex.


Read more about Mentice’s operations, markets, and strategy going forward.

The Annual Report 2023 is available to shareholders and other interested parties at investor.mentice.com/financial-reports-and-presentations/mentice-annual-report-2023. A printed copy can be obtained upon written request to stacy.hammar@mentice.com.

For more information, please contact:
Göran Malmberg, CEO, Mentice
E-post: goran.malmberg@mentice.com
US Mobile. +1 (312) 860 5610
Sweden Mobile +46 (0) 703 09 22 22

About Mentice
Mentice (STO: MNTC) is the world leader in proficiency based simulation solutions for image guided interventional therapies. Our solutions help healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. Mentice solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular, and peripheral interventions are just some of the clinical areas covered by our solutions. Learn more about the features and benefits of Mentice solutions at: www.mentice.com

Marketplace| Nasdaq First North Growth Market, Stockholm | Ticker symbol MNTC
Certified Adviser| FNCA Sweden AB

Image Attachments
AR 2023 IMG

Attachments
Annual Report 2023 Mentice

AKTIEINFORMATION
AktieinformationTop 10 AktieägareCertifierad RådgivareIncitamentsprogram för anställda
PRESSMEDDELANDEN
Alla2022202120202019
FINASIELL KALENDER
Finansiell kalender
FINANSIELLA RAPPORTER
Alla
2022
2021
2020
2019
2023
2024
2025
BOLAGSSTYRNING
BolagsstyrningBolagsordningBolagsstämmorStyrelseKoncernledningRevisorerStyrelseutskottStyrelsens AktieägandeRiktlinjer för ersättningValberedningHållbarhetMedia
ANNAT
KontaktFöretags PresentationTillbaka till Mentice
Data PolicyQuality PolicyDisclaimerTerms
Copyright © 2022 Mentice AB (publ) . All rights reserved.